Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Guenaga

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Blood|March 22, 2007
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaquesRuth Seggewiss, Karin Loré, F Javier Guenaga, et al.
Journal of Virology|July 1, 2011
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01Yuxing Li, Sijy O'Dell, Laura M Walker, et al.
Nature Communications|March 2, 2018
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activityJames J Steinhardt, Javier Guenaga, Hannah L Turner, et al.
Scientific Reports|February 17, 2016
HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo ActivationKaifan Dai, Salar N Khan, Yimeng Wang, et al.
Blood|May 28, 2005
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemiaW Nicholas Haining, Donna S Neuberg, Heather L Keczkemethy, et al.
Journal of Virology|September 23, 2016
Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary BindingNancy S Longo, Matthew S Sutton, Andrea R Shiakolas, et al.
Cell Reports|March 30, 2025
Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelopeMichael V Bick, Eduard Puig, David Beauparlant, et al.
Cell Reports|December 5, 2019
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through ImmunizationK Rachael Parks, Anna J MacCamy, Josephine Trichka, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Journal of Virology|August 10, 2012
HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteinsYuxing Li, Sijy O'Dell, Richard Wilson, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Blood|March 22, 2007
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaquesRuth Seggewiss, Karin Loré, F Javier Guenaga, et al.
Journal of Virology|July 1, 2011
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01Yuxing Li, Sijy O'Dell, Laura M Walker, et al.
Nature Communications|March 2, 2018
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activityJames J Steinhardt, Javier Guenaga, Hannah L Turner, et al.
Scientific Reports|February 17, 2016
HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo ActivationKaifan Dai, Salar N Khan, Yimeng Wang, et al.
Blood|May 28, 2005
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemiaW Nicholas Haining, Donna S Neuberg, Heather L Keczkemethy, et al.
Journal of Virology|September 23, 2016
Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary BindingNancy S Longo, Matthew S Sutton, Andrea R Shiakolas, et al.
Cell Reports|March 30, 2025
Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelopeMichael V Bick, Eduard Puig, David Beauparlant, et al.
Cell Reports|December 5, 2019
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through ImmunizationK Rachael Parks, Anna J MacCamy, Josephine Trichka, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Journal of Virology|August 10, 2012
HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteinsYuxing Li, Sijy O'Dell, Richard Wilson, et al.
Pageof 6